Likewise, p16 protein expression is often used as a surrogate marker for high‐risk HPV, and the correlation between p16 and CDKN2A as well as the correlation between CDKN2A and high‐grade dysplasia/invasive carcinoma in HPV‐associated cases was also high. Here, CDKN2A is linked to invasive carcinoma.